CardiAQ Technologies (Irvine, CA), a developmental-stage medical device company focused on percutaneous mitral heart valve replacement, closed a $37.3M Series B financing. Participants include OrbiMed, Versant Ventures, Advent Life Sciences and Broadview Advisors.